Latest Articles
Model says 'friends, family and doctors called her a liar' until she had proof of agonising illness - MSN
Model says 'friends, family and doctors called her a liar' until she had proof of agonising illness MSN
Published: Jan. 31, 2025, 11:35 p.m.
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer - OncLive
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer OncLive
Published: Jan. 31, 2025, 8:48 p.m.
Laparoscopic Gynecological Procedures Market to Reach USD 61.3 Billion by 2034, Driven by Technologi - PharmiWeb.com
Laparoscopic Gynecological Procedures Market to Reach USD 61.3 Billion by 2034, Driven by Technologi PharmiWeb.com
Published: Jan. 31, 2025, 7:02 p.m.
Mirvie’s RNA Platform Shows Promise in Predicting Severe Fetal Growth Restriction - Femtech Insider
Mirvie’s RNA Platform Shows Promise in Predicting Severe Fetal Growth Restriction Femtech Insider
Published: Jan. 31, 2025, 6:35 p.m.
‘The pain was intense’: why UK women are paying for private gynaecological care - Inkl
‘The pain was intense’: why UK women are paying for private gynaecological care Inkl
Published: Jan. 31, 2025, 1:55 p.m.
‘The pain was intense’: why women in Britain are paying for private gynaecological care - The Guardian
‘The pain was intense’: why women in Britain are paying for private gynaecological care The Guardian
Published: Jan. 31, 2025, 1:54 p.m.
‘The pain was intense’: why UK women are paying for private gynaecological care - The Guardian
‘The pain was intense’: why UK women are paying for private gynaecological care The Guardian
Published: Jan. 31, 2025, 1:54 p.m.
TRα1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility - Nature.com
TRα1 mutant suppresses KLF9 to cause endometrial metaplasia with ectopic IL-33 expression leading to uterine fibrosis and infertility Nature.com
Published: Jan. 31, 2025, 1:21 p.m.
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer - OncLive
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer OncLive
Published: Jan. 30, 2025, 10:54 p.m.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive
Published: Jan. 30, 2025, 10:29 p.m.
Link copied to clipboard!